PSMNano · Probing the fibrillation of Staphylococcal amyloids and their interactions with Membranes at the Nanoscale
Horizon Europe — Marie Skłodowska-Curie Actions
- Duration
- 2022-07-01 → 2024-06-30
- EU contribution
- €161,493
- Participants
- 2
- Scheme
- HORIZON-TMA-MSCA-PF-EF
Lines connect the coordinator with its partners.
Results in brief
Probing the fibrillation of Staphylococcal amyloids and their interactions with Membranes at the Nanoscale
Staphylococcus aureus is a human commensal of the microbiota and the human epithelia, which can turn into an opportunistic pathogen, eventually causing life-threatening diseases. Due to its key role in nosocomial infections and its resistance to many antibiotics, S. aureus constitutes major political and clinical issues worldwide. To elicit less antibioresistance, current drug development strategies focus on targeting virulence determinants of S. aureus, and require, first and foremost, a comprehensive understanding of the molecular mechanisms S. aureus has developed to passively or actively evade host elimination. In this context, S. aureus virulence has been shown to critically depend on the production of the phenol-soluble modulins α3 (PSMα3) peptides, that have recently drawn much attention due to their key roles in invasion and infection. Overproduced by multiresistant strains, those amphipathic peptides not only exhibit cytolytic activities towards human cells but also eventually trigger pro-inflammation processes in a receptor (FPR2)-dependent manner. Such diverse functions rely on specific mechanisms of interaction, either recognition and/or perturbation, with cell membranes. Interestingly, PSMα3 can self-assemble into insoluble fibrils, characterized by the unique cross-α structure, reminiscent of the cross-β scaffold of pathogenic amyloids studied in light of neurodegenerative disorders. Based on recent controversial data, the cross-α fibrillation would be required for PSMα3 to exert its functions. Yet, most of the current knowledge arises from ensemble techniques, only providing average behavior of all PSMα3 entities formed along the fibrillation, and thus partially ignoring the complex interplay between the structural polymorphism of PSMα3, and their interactions with cells. This project thus aims at providing insights into the structure-function relationship of the virulent factors PSMα3, by investigating, at the cellular and molecular levels, their underestimated dynamic interactions with cell membranes, the first key steps towards their physiological functions in S. aureus. To reach this objective, Combination of in vitro and in cellulo experiments, based on Atomic Force Microscopy (AFM)-related techniques, combined with complementary biophysical approaches, will be performed to: (1) unravel the fibrillation kinetics and structures of PSMα3 interacting with membranes, (2) decipher the mechanisms governing the interaction of PSMα3 and membranes, and (3) unveil the receptor-mediated processes turning PSMα3 into proinflammatory agents.
Data: CORDIS, © European Union
Project objective
Phenol-soluble modulins α3 (PSMα3) are functional amyloids involved in the virulence of Staphylococcus aureus, a multi-drug resistant pathogen under the surveillance of the European Union (EU). The project PSMNano aims at unveiling the molecular mechanisms driving PSMα3 interactions with cell membranes, which lead to their cytotoxic and proinflammatory activities, with a focus on the impact of amyloid fibrillation. So far poorly known, dissecting those mechanisms is yet critical to efficiently target PSMα3 activities, in turn S. aureus pathogenicity, and avoid the pandemics foreseen by the EU in the coming decades. Thanks to atomic force microscopy coupled to complementary multiscale biophysical tools, PSMNano will provide high spatiotemporal resolution multiparametric imaging of those interactions, while quantifying their affinity and energetic landscape, on both mimetic models and living cells. Remarkably, single-molecule experiments and cell budding will help decipher the forces driving the FPR2 receptor-dependent role of PSMα3. The expertise of the fellow Dr. Mathelié-Guinlet in surface chemistry and nanobiophysics related to bacterial virulence, the complementary knowledge she will acquire from the supervisor Pr. Molinari on membrane models design and spectroscopic investigations of amyloids, and the cutting-edge technical platforms of the host institution, CBMN (University of Bordeaux, France) will be instrumental for the success of this interdisciplinary project. The fundamental insights brought by the understanding of the role of PSMs-cell membrane interactions in S. aureus pathogenesis could set the stage for the design of novel therapeutics, e.g. inhibitors of PSMα3 activity. PSMNano could also open up avenues for standardized protocols to characterize amyloid-membrane interactions, involved in degenerative diseases. With valuable short- and long-term outcomes, this project will undoubtedly strengthen the competitiveness of the EU health program.
Original text from CORDIS.
Participants
Links
- View on CORDIS
- DOI: 10.3030/101064573
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e50fe9f047&appId=PPGMS
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5f5b7097d&appId=PPGMS
Data: CORDIS, © European Union
